Systematic review: The treatment of noncardiac chest pain

Alimentary Pharmacology and Therapeutics

Volumn 35, Issue 1, 2012, Pages 5-14

  Hershcovici, T ^a   Achem, S R ^b   Jha, L K ^a   Fass, R ^a  

^a SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CIMETROPIUM; CLOMIPRAMINE; DIGESTIVE TRACT SPASMOLYTIC AGENT; DILTIAZEM; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMIPRAMINE; IPRATROPIUM BROMIDE; LANSOPRAZOLE; NIFEDIPINE; NITRATE; OMEPRAZOLE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; THEOPHYLLINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ALTERNATIVE MEDICINE; BEDTIME DOSAGE; COGNITIVE THERAPY; COMORBIDITY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG WITHDRAWAL; ESOPHAGEAL HYPERSENSITIVITY; ESOPHAGEAL MOTOR DISORDER; ESOPHAGUS ACHALASIA; ESOPHAGUS DISEASE; ESOPHAGUS FUNCTION DISORDER; ESOPHAGUS SPASM; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL MOTILITY DISORDER; HEARTBURN; HIGH AMPLITUDE PERISTALTIC ESOPHAGEAL CONTRACTION; HUMAN; HYPERSENSITIVITY; HYPERTENSIVE LOWER ESOPHAGEAL SPHINCTER; HYPERTENSIVE LOWER ESOPHAGUS SPHINCTER; HYPNOSIS; HYPOTENSION; JOHREI THERAPY; LIBIDO DISORDER; LOWER ESOPHAGEAL SPHINCTER DYSFUNCTION; MENTAL DISEASE; NONCARDIAC CHEST PAIN; PRIORITY JOURNAL; RESTLESSNESS; RETROGRADE EJACULATION; REVIEW; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ANTI-ULCER AGENTS; CHEST PAIN; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL MOTILITY DISORDERS; GASTROESOPHAGEAL REFLUX; HUMANS; PAIN MEASUREMENT; PROTON PUMP INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 83555164632     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2011.04904.x     Document Type: Review

References (77)

1. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd,. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56. (Pubitemid 27181367)
2. Ford AC, Suares NC, Talley NJ,. Meta-analysis: the epidemiology of noncardiac chest pain in the community. Aliment Pharmacol Ther 2011; 34: 172-80.
3. Jerlock M, Welin C, Rosengren A, Gaston-Johannson F,. Pain characteristics in patients with unexplained chest pain and patients with ischemic heart disease. Eur J Cardiovasc Nurs 2007; 6: 130-6. (Pubitemid 46759519)
4. Fass R, Navarro-Rodriguez T,. Noncardiac chest pain. J Clin Gastroenterol 2008; 42: 636-46. (Pubitemid 351572278)
5. Richter JE, Bradley LA, Castell DO,. Esophageal chest pain: current controversies in pathogenesis, diagnosis, and therapy. Ann Intern Med 1989; 110: 66-78. (Pubitemid 19032794)
6. Fass R, Achem SR,. Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motil 2011; 17: 110-23.
7. Achem SR,. Treatment of non-cardiac chest pain. Dis Mon 2008; 54: 642-70.
8. Fass R,. Evaluation and diagnosis of noncardiac chest pain. Dis Mon 2008; 54: 627-41.
9. Fass R, Achem SR,. Noncardiac chest pain: diagnostic evaluation. Dis Esophagus 2011 [Epub ahead of print].
10. Dickman R, Mattek N, Holub J, Peters D, Fass R,. Prevalence of upper gastrointestinal tract findings in patients with noncardiac chest pain versus those with gastroesophageal reflux disease (GERD)-related symptoms: results from a national endoscopic database. Am J Gastroenterol 2007; 102: 1173-9. (Pubitemid 46802000)
11. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 339: b2700.
12. DeMeester TR, O'Sullivan GC, Bermudez G, Midell A, Cimochowski GE, O'Drobinak J,. Esophageal function in patients with angina-type chest pain and normal coronary angiograms. Ann Surg 1982; 196: 488-98. (Pubitemid 12030727)
13. Achem SR, Kolts BE, Wears R, Burton L, Richter JE,. Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux. Am J Gastroenterol 1993; 88: 187-92. (Pubitemid 23053467)
14. Stahl WG, Beton RR, Johnson CS, Brown CL, Waring JP,. Diagnosis and treatment of patients with gastroesophageal reflux and noncardiac chest pain. South Med J 1994; 87: 739-42. (Pubitemid 24218229)
15. Chambers J, Cooke R, Anggiansah A, Owen W,. Effect of omeprazole in patients with chest pain and normal coronary anatomy: initial experience. Int J Cardiol 1998; 65: 51-5. (Pubitemid 28338265)
16. Achem SR, Kolts BE, MacMath T, et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997; 42: 2138-45. (Pubitemid 27502004)
17. Flook N, Moayyedi P, Dent J, et al. Esomeprazole for treatment of unexplained chest pain in primary care: a prospective, randomized, double-blind, placebo-controlled multicenter study. Gastroenterology 2007; 132 (4 Suppl 2): A-480, T1163.
18. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115: 42-9. (Pubitemid 28307286)
19. Pandak WM, Arezo S, Everett S, et al. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol 2002; 35: 307-14.
20. Xia HH, Lai KC, Lam SK, et al. Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Aliment Pharmacol Ther 2003; 17: 369-77. (Pubitemid 36259399)
21. Bautista J, Fullerton H, Briseno M, Cui H, Fass R,. The effect of an empirical trial of high-dose lansoprazole on symptom resonse of patients with non-cardiac chest pain - a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 2004; 19: 1123-30. (Pubitemid 38703525)
22. Dickman R, Emmons S, Cui H, et al. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther 2005; 22: 547-55. (Pubitemid 41360801)
23. Kim JH, Sinn DH, Son HJ, Kim JJ, Rhee JC, Rhee PL,. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients. J Gastroenterol Hepatol 2009; 24: 1504-9.
24. Orlando RC, Bozymski EM,. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med 1973; 289: 23-5.
25. Swamy N,. Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites. Gastroenterology 1977; 72: 23-7. (Pubitemid 8002445)
26. Parker WA, MacKinnon GL,. Nitrites in the treatment of diffuse esophageal spasm. Drug Intell Clin Pharm 1981; 15: 806-7. (Pubitemid 12204130)
27. Shafran I,. Drug treatment of esophageal spasm. Gastroenterology 1982; 83: 1334-5.
28. Mellow M,. Symptomatic diffuse esophageal spasm. Manometric follow-up and response to cholinergic stimulation and cholinesterase inhibition. Gastroenterology 1977; 73: 237-40. (Pubitemid 8152437)
29. Millaire A, Ducloux G, Marquand A, Vaksmann G,. Nitroglycerin and angina with angiographically normal coronary vessels. Clinical effects and effects on esophageal motility. Arch Mal Coeur Vaiss 1989; 82: 63-8. (Pubitemid 19056381)
30. Eherer AJ, Schwetz I, Hammer HF, et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002; 50: 758-64. (Pubitemid 34539035)
31. Bortolotti M, Pandolfo N, Giovannini M, Mari C, Miglioli M,. Effect of Sildenafil on hypertensive lower oesophageal sphincter. Eur J Clin Invest 2002; 32: 682-5. (Pubitemid 36223398)
32. Agrawal A, Tutuian R, Hila A, Castell DO,. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report. Dig Dis Sci 2005; 50: 2059-62. (Pubitemid 41504089)
33. Bassotti G, Gaburri M, Imbimbo BP, et al. Manometric evaluation of cimetropium bromide activity in patients with the nutcracker oesophagus. Scand J Gastroenterol 1988; 23: 1079-84.
34. Triadafilopoulos G, Tsang HP,. Olfactory stimuli provoke diffuse esophageal spasm: reversal by ipratropium bromide. Am J Gastroenterol 1996; 91: 2224-7. (Pubitemid 26338985)
35. Blackwell JN, Holt S, Heading RC,. Effect of nifedipine on oesophageal motility and gastric emptying. Digestion 1981; 21: 50-6. (Pubitemid 10001266)
36. Davies HA, Lewis M, Rhodes J, Henderson A,. Nifedipine for relief of esophageal chest pain? N Engl J Med 1982; 307: 1274. (Pubitemid 12001367)
37. Nasrallah SM,. Nifedipine in the treatment of diffuse oesophageal spasm. Lancet 1982; 2: 1285.
38. Nasrallah SM, Tommaso CL, Singleton RT, Backhaus EA,. Primary esophageal motor disorders: clinical response to nifedipine. South Med J 1985; 78: 312-15. (Pubitemid 15102012)
39. Thomas E, Witt P, Willis M, Morse J,. Nifedipine therapy for diffuse esophageal spasm. South Med J 1986; 79: 847-9.
40. Davies HA, Lewis MJ, Rhodes J, Henderson AH,. Trial of nifedipine for prevention of oesophageal spasm. Digestion 1987; 36: 81-3. (Pubitemid 17028578)
41. Banciu T, Iova M, Biroasiu G, Susan L,. The diagnostic and therapeutic contribution of calcium channel inhibitors (nifedipine) in esophageal spasm. Med Interne 1990; 28: 69-71.
42. Traube M, Hongo M, Magyar L, McCallum RW,. Effects of nifedipine in achalasia and in patients with high-amplitude peristaltic esophageal contractions. JAMA 1984; 252: 1733-6. (Pubitemid 14009857)
43. Richter JE, Dalton CB, Bradley LA, Castell DO,. Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus. Gastroenterology 1987; 93: 21-8. (Pubitemid 17084088)
44. Richter JE, Spurling TJ, Cordova CM, Castell DO,. Effects of oral calcium blocker, diltiazem, on esophageal contractions. Studies in volunteers and patients with nutcracker esophagus. Dig Dis Sci 1984; 29: 649-56. (Pubitemid 14099900)
45. Cattau EL Jr, Castell DO, Johnson DA, et al. Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol 1991; 86: 272-6.
46. Drenth JP, Bos LP, Engels LG,. Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Aliment Pharmacol Ther 1990; 4: 411-6. (Pubitemid 20268691)
47. Cannon RO 3rd, Quyyumi AA, Mincemoyer R, et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 1994; 330: 1411-7. (Pubitemid 24139233)
48. Handa M, Mine K, Yamamoto H, et al. Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach. J Clin Gastroenterol 1999; 28: 228-32. (Pubitemid 29141102)
49. Prakash C, Clouse RE,. Long-term outcome from tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci 1999; 44: 2373-9. (Pubitemid 30027348)
50. Clouse RE, Lustman PJ, Eckert TC, Ferney DM, Griffith LS,. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial. Gastroenterology 1987; 92: 1027-36. (Pubitemid 17046322)
51. Varia I, Logue E, O'Connor C, et al. Randomized trial of sertraline in patients with unexplained chest pain of noncardiac origin. Am Heart J 2000; 140: 367-72.
52. Doraiswamy PM, Varia I, Hellegers C, et al. A randomized controlled trial of paroxetine for noncardiac chest pain. Psychopharmacol Bull 2006; 39: 15-24.
53. Spinhoven P, Van Der Does AJ, Van Dijk E, Van Rood YR,. Heart-focused anxiety as a mediating variable in the treatment of noncardiac chest pain by cognitive-behavioral therapy and paroxetine. J Psychosom Res 2010; 69: 227-35.
54. Lee H, Kim JH, Min BH, et al. Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Am J Gastroenterol 2010; 105: 1504-12.
55. Rao SS, Mudipalli RS, Remes-Troche JM, Utech CL, Zimmerman B,. Theophylline improves esophageal chest pain - a randomized, placebo-controlled study. Am J Gastroenterol 2007; 102: 930-8. (Pubitemid 46698228)
56. Rao SS, Mudipalli RS, Mujica V, Utech CL, Zhao X, Conklin JL,. An open-label trial of theophylline for functional chest pain. Dig Dis Sci 2002; 47: 2763-8. (Pubitemid 35471620)
57. Miller LS, Parkman HP, Schiano TD, et al. Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996; 41: 2025-31. (Pubitemid 26366804)
58. Cassidy MJ, Schiano TD, Adrain AL, et al. Botulinum toxin injection for the treatment of diffuse esophageal spasm (abstract). Am J Gastroenterol 1996; 91: 1884.
59. Nebendahl JC, Brand B, von Schrenck T, et al. Effective treatment of diffuse esophageal spasm by endoscopic injection of botulinum toxin (abstract). Gastroenterology 1998; 114: A240.
60. Nebendahl JC, Brand B, von Schrenck T, et al. Treatment of diffuse esophageal spasm with botulinum toxin: a prospective study with 6 month follow up (abstract). Gastroenterology 1999; 116: A802.
61. Storr M, Allescher HD, Rosch T, Born P, Weigert N, Classen M,. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc 2001; 54: 754-9. (Pubitemid 33668684)
62. Miller LS, Pullela SV, Parkman HP, et al. Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal junction. Am J Gastroenterol 2002; 97: 1640-6. (Pubitemid 34761383)
63. Mathews S, Cohen H, Kline M,. Botulinum toxin injection improves symptomatic hypertensive lower esophageal sphincter. Gastroenterology 1998; 114 (Suppl 1): A800.
64. Jones MP,. Botulinum toxin in hypertensive lower esophageal sphincter. Am J Gastroenterol 1996; 91: 1283-4. (Pubitemid 26175515)
65. Lacy BE, Zayat EN, Crowell MD,. Case report: botulinum toxin in hypertensive lower esophageal sphincter: a manometric case study. Dysphagia 2002; 17: 75-80. (Pubitemid 36918855)
66. Vanuytsel T, Bisschops R, Mimidis K, et al. A sham-controlled study of injection of botulinum toxin in diffuse esophageal spasm. Gastroenterology 2008; 134 (4 Suppl 1): A-14.
67. van Peski-Oosterbaan AS, Spinhoven P, van Rood Y, van der Does JW, Bruschke AV, Rooijmans HG,. Cognitive-behavioral therapy for noncardiac chest pain: a randomized trial. Am J Med 1999; 106: 424-9. (Pubitemid 29190595)
68. Klimes I, Mayou RA, Pearce MJ, Coles L, Fagg JR,. Psychological treatment for atypical non-cardiac chest pain: a controlled evaluation. Psychol Med 1990; 20: 605-11. (Pubitemid 20374825)
69. Jones H, Cooper P, Miller V, Brooks N, Whorwell PJ,. Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy. Gut 2006; 55: 1403-8. (Pubitemid 44476782)
70. So JB, Zeitels SM, Rattner DW,. Outcomes of atypical symptoms attributed to gastroesophageal reflux treated by laparoscopic fundoplication. Surgery 1998; 124: 28-32. (Pubitemid 28354682)
71. Chen RY, Thomas RJ,. Results of laparoscopic fundoplication where atypical symptoms coexist with oesophageal reflux. Aust N Z J Surg 2000; 70: 840-2.
72. Farrell TM, Richardson WS, Trus TL, Smith CD, Hunter JG,. Response of atypical symptoms of gastro-oesophageal reflux to antireflux surgery. Br J Surg 2001; 88: 1649-52. (Pubitemid 33124245)
73. Patti M, Molena D, Perretta S, Way LW,. Gastroesophageal reflux disease (GERD) and chest pain. Results of laparoscopic antireflux surgery. Surg Endosc 2002; 16: 563-6. (Pubitemid 34263411)
74. Rakita S, Villadolid D, Thomas A, et al. Laparoscopic Nissen fundoplication offers high patient satisfaction with relief of extraesophageal symptoms of gastroesophageal reflux disease. Am Surg 2006; 72: 207-12. (Pubitemid 351837697)
75. Ellis FH Jr,. Esophagomyotomy for noncardiac chest pain resulting from diffuse esophageal spasm and related disorders. Am J Med 1992; 92 (5A): 129S-31S.
76. Gasiorowska A, Navarro-Rodriguez T, Dickman R, et al. Clinical trial: the effect of Johrei on symptoms of patients with functional chest pain. Aliment Pharmacol Ther 2009; 29: 126-34.
77. Borjesson M, Rolny P, Mannheimer C, Pilhall M,. Nutcracker oesophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole. Aliment Pharmacol Ther 2003; 18: 1129-35. (Pubitemid 38021599)